An Open-label Follow-up Study of 0.01 mg/kg/Day to 0.03 mg/kg/Day Prucalopride (R108512) Oral Solution in Paediatric Subjects, Aged ≥ 4 to ≤ 12 Years With Functional Faecal Retention (FFR), Who Participated in the PRU-USA-12.

Trial Profile

An Open-label Follow-up Study of 0.01 mg/kg/Day to 0.03 mg/kg/Day Prucalopride (R108512) Oral Solution in Paediatric Subjects, Aged ≥ 4 to ≤ 12 Years With Functional Faecal Retention (FFR), Who Participated in the PRU-USA-12.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Apr 2015

At a glance

  • Drugs Prucalopride (Primary)
  • Indications Constipation
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shire-Movetis NV
  • Most Recent Events

    • 24 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top